• 作者：Maria Luisa Lozano Sá ; nchez^a ; Mariano Leal Herná ; ndez^a ; ^{jabellan@pdi.ucam.edu} ; Jos&#233 ; Abellá ; n Huerta^b ; Purificació ; n Gó ; mez Jara^a ; Enrique Jos&#233 ; Ortí ; n Ortí ; n^a ; Jos&#233 ; Abellá ; n Alemá ; n^a
• 关键词：Epidemiologí ; a ; Estilo de vida ; Estudio transversal
• 刊名：Atenci¨®n Primaria
• 出版年：2013
• 出版时间：February, 2013
• 年：2013
• 卷：45
• 期：2
• 页码：92-100
• 全文大小：317 K

Objective

To assess whether there are differences in the immigrant population in terms of the years since their arrival in Spain and their geographical area of origin.

Design

A cross-sectional study was conducted in three immigrant groups.

Participants

The groups selected were: a group of Latin American immigrants (298), a group of North African immigrants (130) and a group from Eastern Europe (114). A control group of 100 from a Spanish population of similar age and sex was also included.

Methods

Anthropometric variables were measured, including biochemical inflammatory markers, blood pressure and cardiovascular risk estimation according to the tables of the European Societies of Hypertension and Cardiology.

Results

The cardiovascular risk of the three groups of immigrants is similar between them (added cardiovascular risk high or very high at 5.5 % in Latin Americans, 4.3 % in North Africans, and 1.6 % in immigrants from eastern countries), but significantly lower than the Spanish control group (28 % ). After 8 years in Spain, cardiovascular risk increases in the three groups of immigrants, with those from North Africa and eastern countries being comparable to the Spanish group (added cardiovascular risk high or very high of 18.5 % in North Africans, and 20 % in group from eastern countries). This cardiovascular risk was higher than the other groups, including the Spanish control group (Latin American immigrants 48.7 % vs 28 % in Spanish group).

Conclusions

The cardiovascular risk of immigrants increases over the years in Spain, with this increase being higher if they come from Latin America. This increase becomes clinically significant after the 8 years of stay in Spain.